英特集团 (000411.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

9.4x

Market Cap

CNY 5.41B

MomentumView details →

1D Return

−0.93%

YTD Return

−19.84%

RSI (14)

61.0

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

9.4x

Market Cap

CNY 5.41B

RSI (14)

61.0

MomentumView details →

1D Return

−0.93%

YTD Return

−19.84%

ProfitabilityView details →

Gross Margin

7.07%

Net Margin

1.42%

EBITDA Margin

2.84%

ROE (TTM)

8.89%

ROA (TTM)

2.75%

Asset Turnover

1.97x

GrowthView details →

Revenue YoY

+1.95%

EPS YoY

−9.68%

FCF YoY

+307.81%

Revenue CAGR 3Y

+3.23%

EPS CAGR 3Y

+10.58%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.79x

Current Ratio

1.35x

Quick Ratio

0.95x

Div Yield

3.46%

Div Rate

CNY 0.35

Div Growth 1Y

−7.62%

Financials snapshotView financials →

Revenue (TTM)

33.84B

Net Income (TTM)

480.59M

Op. CF (TTM)

1.61B

Latest newsMore news →

On August 18, 2026, Yingte Group and Hangzhou PICC signed a strategic cooperation agreement to jointly launch a provincial exclusive specialty drug commercial insurance product called 'Yingte-PICC Yao Kangbao'.18d ago

Similar companies

武商集团000501.SZ 天虹股份002419.SZ 漱玉平民301017.SZ 三态股份301558.SZ 华凯易佰300592.SZ 信邦制药002390.SZ Find similar companies →

Latest newsMore news →

On August 18, 2026, Yingte Group and Hangzhou PICC signed a strategic cooperation agreement to jointly launch a provincial exclusive specialty drug commercial insurance product called 'Yingte-PICC Yao Kangbao'.18d ago